Buy_老虎社区_美港股上老虎

2021-04-23

Buy

Why Ocugen Shares Skyrocketed Today<blockquote>为什么Ocugen股价今天飙升</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":376791650,"tweetId":"376791650","gmtCreate":1619146781070,"gmtModify":1634288194172,"author":{"id":3568290085916641,"idStr":"3568290085916641","authorId":3568290085916641,"authorIdStr":"3568290085916641","name":"EquityKing","avatar":"https://static.tigerbbs.com/6cddc9965d334dafd119ae3d57fb077d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Buy</body></html>","htmlText":"<html><head></head><body>Buy</body></html>","text":"Buy","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/376791650","repostId":1137961906,"repostType":4,"repost":{"id":"1137961906","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1619145390,"share":"https://www.laohu8.com/m/news/1137961906?lang=zh_CN&edition=full","pubTime":"2021-04-23 10:36","market":"us","language":"en","title":"Why Ocugen Shares Skyrocketed Today<blockquote>为什么Ocugen股价今天飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137961906","media":"Benzinga","summary":"Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours","content":"Ocugen Inc&nbsp;OCGN 42.92%&nbsp;shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.<blockquote>Ocugen公司OCGN 42.92%股价在常规交易中飙升42.9%，在周四盘后交易中又飙升11%。</blockquote><img src=\"https://static.tigerbbs.com/a5596cd8cf4db1a7bb5b759d4f269eeb\" tg-width=\"1022\" tg-height=\"459\"><blockquote></blockquote>What Happened:&nbsp;The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.<blockquote>发生了什么：在Ocugen合伙人宣布积极的临床数据以及Roth Capital分析师Zegbeh Jallah采取看涨立场后，该股飙升，Zegbeh Jallah对该股给予买入评级，12个月目标价为10美元。</blockquote>Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.<blockquote>周三早些时候，Ocugen的共同开发合作伙伴Bharat Biotech表示，对COVID-19候选疫苗科瓦克辛3期的第二次中期分析显示，其对轻度、中度和重度疾病的有效率为78%。</blockquote>The vaccine is reportedly 100% effective against severe forms of viral illness.<blockquote>据报道，这种疫苗对严重的病毒性疾病100%有效。</blockquote>In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.<blockquote>Jallah在一份说明中表示，Ocugen有足够的信息支持在美国提交紧急使用授权申请。</blockquote>“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.<blockquote>这位分析师写道：“如果获得批准，这可能会为Ocugen带来巨大的创收机会。”</blockquote>Jallah said that management has confirmed plans to make Covaxin available in the U.S.<blockquote>贾拉表示，管理层已确认在美国提供科瓦克辛的计划。</blockquote>The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.<blockquote>根据Jallah的说法，该疫苗的第一批将在美国食品药品监督管理局批准的设施中进行测试和发布。</blockquote>Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.<blockquote>与此同时，Bharat Biotech正在加大生产力度，每年生产7亿剂COVID-19疫苗。</blockquote>Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.<blockquote>本月早些时候，有报道称Ocugen计划在美国销售1亿剂科瓦克辛疫苗。</blockquote>Price Action:&nbsp;Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.<blockquote>价格走势：Ocugen股价周四收盘上涨42.92%，至9.29美元，在盘后交易中又上涨近11%，至10.31美元。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ocugen Shares Skyrocketed Today<blockquote>为什么Ocugen股价今天飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ocugen Shares Skyrocketed Today<blockquote>为什么Ocugen股价今天飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nBenzinga \n2021-04-23 10:36\n</div>\n</div>\n</h4>\n</header>\n<article>\nOcugen Inc&nbsp;OCGN 42.92%&nbsp;shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.<blockquote>Ocugen公司OCGN 42.92%股价在常规交易中飙升42.9%，在周四盘后交易中又飙升11%。</blockquote><img src=\"https://static.tigerbbs.com/a5596cd8cf4db1a7bb5b759d4f269eeb\" tg-width=\"1022\" tg-height=\"459\"><blockquote></blockquote>What Happened:&nbsp;The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.<blockquote>发生了什么：在Ocugen合伙人宣布积极的临床数据以及Roth Capital分析师Zegbeh Jallah采取看涨立场后，该股飙升，Zegbeh Jallah对该股给予买入评级，12个月目标价为10美元。</blockquote>Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.<blockquote>周三早些时候，Ocugen的共同开发合作伙伴Bharat Biotech表示，对COVID-19候选疫苗科瓦克辛3期的第二次中期分析显示，其对轻度、中度和重度疾病的有效率为78%。</blockquote>The vaccine is reportedly 100% effective against severe forms of viral illness.<blockquote>据报道，这种疫苗对严重的病毒性疾病100%有效。</blockquote>In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.<blockquote>Jallah在一份说明中表示，Ocugen有足够的信息支持在美国提交紧急使用授权申请。</blockquote>“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.<blockquote>这位分析师写道：“如果获得批准，这可能会为Ocugen带来巨大的创收机会。”</blockquote>Jallah said that management has confirmed plans to make Covaxin available in the U.S.<blockquote>贾拉表示，管理层已确认在美国提供科瓦克辛的计划。</blockquote>The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.<blockquote>根据Jallah的说法，该疫苗的第一批将在美国食品药品监督管理局批准的设施中进行测试和发布。</blockquote>Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.<blockquote>与此同时，Bharat Biotech正在加大生产力度，每年生产7亿剂COVID-19疫苗。</blockquote>Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.<blockquote>本月早些时候，有报道称Ocugen计划在美国销售1亿剂科瓦克辛疫苗。</blockquote>Price Action:&nbsp;Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.<blockquote>价格走势：Ocugen股价周四收盘上涨42.92%，至9.29美元，在盘后交易中又上涨近11%，至10.31美元。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137961906","content_text":"Ocugen Inc OCGN 42.92% shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday.What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a Buy rating on the stock and a 12-month price target of $10.Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows itdemonstrated 78% efficiencyin mild, moderate, and severe disease.The vaccine is reportedly 100% effective against severe forms of viral illness.In a note, Jallah said that Ocugen has sufficient information to support the filing of an Emergency Use Authorization application in the United States.“If granted, this could lead to a significant revenue generating opportunity for Ocugen,” wrote the analyst.Jallah said that management has confirmed plans to make Covaxin available in the U.S.The vaccine’s initial batches will undergo test and release at a U.S. facility approved by the Food and Drug Administration, as per Jallah.Meanwhile, Bharat Biotech isramping up manufacturingto produce 700 million COVID-19 vaccine doses annually.Earlier in the month, it was reported that Ocugen plans to sell100 million Covaxin dosesin the U.S.Price Action: Ocugen shares closed 42.92% higher at $9.29 on Thursday and rose another almost 11% to $10.31 in the after-hours trading.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1955,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/376791650"}